<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43(3)</volume><submitter>Heeman F</submitter><pubmed_abstract>Alzheimer's disease is characterized by regional reductions in cerebral blood flow (CBF). Although the gold standard for measuring CBF is [&lt;sup>15&lt;/sup>O]H&lt;sub>2&lt;/sub>O PET, proxies of relative CBF, derived from the early distribution phase of amyloid and tau tracers, have gained attention. The present study assessed precision of [&lt;sup>15&lt;/sup>O]H&lt;sub>2&lt;/sub>O derived relative and absolute CBF, and compared precision of these measures with that of (relative) CBF proxies. Dynamic [&lt;sup>15&lt;/sup>O]H&lt;sub>2&lt;/sub&gt;O, [&lt;sup>18&lt;/sup>F]florbetapir and [&lt;sup>18&lt;/sup>F]flortaucipir PET test-retest (TrT) datasets with eleven, nine and fourteen subjects, respectively, were included. Analyses were performed using an arterial input model and/or a simplified reference tissue model, depending on the data av</pubmed_abstract><journal>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</journal><pagination>369-378</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9941867</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals.</pubmed_title><pmcid>PMC9941867</pmcid><pubmed_authors>Visser D</pubmed_authors><pubmed_authors>van der Flier WM</pubmed_authors><pubmed_authors>Verfaillie S</pubmed_authors><pubmed_authors>Lammertsma AA</pubmed_authors><pubmed_authors>Golla SS</pubmed_authors><pubmed_authors>Heeman F</pubmed_authors><pubmed_authors>Timmers T</pubmed_authors><pubmed_authors>Pijnenburg YA</pubmed_authors><pubmed_authors>van Berckel BN</pubmed_authors><pubmed_authors>Yaqub M</pubmed_authors><pubmed_authors>Boellaard R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals.</name><description>Alzheimer's disease is characterized by regional reductions in cerebral blood flow (CBF). Although the gold standard for measuring CBF is [&lt;sup>15&lt;/sup>O]H&lt;sub>2&lt;/sub>O PET, proxies of relative CBF, derived from the early distribution phase of amyloid and tau tracers, have gained attention. The present study assessed precision of [&lt;sup>15&lt;/sup>O]H&lt;sub>2&lt;/sub>O derived relative and absolute CBF, and compared precision of these measures with that of (relative) CBF proxies. Dynamic [&lt;sup>15&lt;/sup>O]H&lt;sub>2&lt;/sub&gt;O, [&lt;sup>18&lt;/sup>F]florbetapir and [&lt;sup>18&lt;/sup>F]flortaucipir PET test-retest (TrT) datasets with eleven, nine and fourteen subjects, respectively, were included. Analyses were performed using an arterial input model and/or a simplified reference tissue model, depending on the data av</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-05T11:31:51.235Z</modification><creation>2025-02-18T22:53:19.036Z</creation></dates><accession>S-EPMC9941867</accession><cross_references><pubmed>36271598</pubmed><doi>10.1177/0271678X221135270</doi></cross_references></HashMap>